Ann: Preliminary Final Report Appendix 4E , page-18

This below quote is not quite about the 4E but in context I think is really important at showing were OBJ is sitting.
The quote is from GSK CEO MR Witty, the article is about R & D funding and research and the big shake out

"There is tremendous opportunity for the few companies who solve the R&D equation," Witty told reporters, according to a report in the Philadelphia Inquirer. "It's the companies who deliver multiple new products, not one or two, that address material clinical needs of patients and address the economic needs of the payers--so they are fairly priced, if I can put it that way."

OBJ fits this equation perfectly, lets hope obj keep on making it through the culling programmes.
OBJ 4E clearly shows diversity in their technology..
for full article
http://www.fiercebiotech.com/story/gsk-chief-sees-big-shakeout-following-rd-showdown/2011-07-28?utm_medium=nl&utm_source=internal

cheers